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Background/aim: Kisspeptin is a neuropeptide with a primary role on the onset of puberty and has beneficial effects on ischemia/
reperfusion (I/R) injury. In this study, we aimed to investigate the effect of kisspeptin administration on striatal I/R injury in mice.
Material and methods: Forty adult C57/BL6 mice were randomly divided into four groups: Sham, Kisspeptin, I/R, and I/R + Kisspeptin
groups. The groups were administered with either physiological saline (Sham and I/R groups) or kisspeptin (Kisspeptin and I/R +
Kisspeptin groups) intraperitoneally 40 min before the operation. A microdialysis probe was placed in the right striatum according
to stereotaxic coordinates. During the experimental period, artificial cerebrospinal fluid was passed through the micropump. Then,
transient cerebral ischemia was established by compressing both common carotid arteries with an aneurysm clip for 15 min and animals
were reperfused for 2 h. Throughout the process of microdialysis (before, during and after I/R period), samples were collected to
measure dopamine (DA), noradrenaline (NA), and 3,4-dihydroxyphenylglycine (DHPG) at intervals of 20 min continuously. At the
end of the reperfusion period, the animals were decapitated, striatum was dissected, half of the animals were used for oxidative stress
analyses (reduced glutathione, glutathione S-transferase (GST), superoxide dismutase (SOD), malondialdehyde (MDA), and the other
half were used for histopathology analyses.
Results: Number of glial cells was significantly increased in kisspeptin-administered groups. DA levels in ischemic animals were
decreased by kisspeptin administration (p < 0.0001). NA levels were reduced in animals administered with kisspeptin without I/R injury
(p < 0.05). DHPG levels reduced during the reperfusion period in ischemic animals (p < 0.05). Kisspeptin did not exhibit a significant
antioxidant activity in the ischemic animals, while GST and SOD levels were reduced in the I/R + kisspeptin group compared to the
kisspeptin group (p < 0.05).
Conclusion: Our results suggest that kisspeptin may be regulating the neurotransmitter release and metabolism, as well as inflammatory
response in brain upon I/R injury.
Key words: Cerebral ischemia/reperfusion injury, kisspeptin, neurotransmitter, mouse, oxidative stress

1. Introduction
Cerebral ischemia/reperfusion (I/R) injury is a known
complication of returning blood flow to ischemic brain
tissue, and secretion of proteases and free radicals
to the wounded area is a result of the reintroduction
of oxygen and white blood cells via blood flow [1].
Cerebral I/R injury frequently occurs in patients with
cerebral palsy upon reintroduction of blood flow, leads
to severe neurological deficits [2]. Pharmacological
investigations have indicated by brain microdialysis
studies that neurotransmitters may be released upon
ischemia [3,4].

The prefrontal cortex circuits travel along a portion of
the basal ganglion-caudate nucleus, globus pallidus, and
thalamus [5]. One of the main nuclei forming the basal
ganglia is the striatum that consists of caudate nucleus,
putamen, ventral striatum and the striatum entering the
basal nucleus [5]. The dorsolateral prefrontal cortex [6],
orbitofrontal cortex [7], and dorsal anterior cingulate
cortex have projections to the striatum that play a role
in behavioural flexibility [8], where disruptions can
lead to various behavioural or emotional deficits [9,11].
Impaired catecholamine activity may also lead to circuitry
dysregulation in these regions [12,14].
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Kisspeptin receptor (Kiss1r) is found in various
regions in the brain including pons, midbrain, thalamus,
hypothalamus, hippocampus, amygdala, cortex, frontal
cortex, and striatum as well as in the peripheral organs
such as liver and intestine [15]. Kisspeptin, which is mainly
released from the hypothalamus [15], is also secreted from
the cerebral cortex and hippocampus [16,17]. In addition,
it was reported that peripheral kisspeptin can reach GnRH
neurons and pass through the blood brain barrier [18].
Kisspeptin plays a role in vasoconstriction besides its
neurological functions. In the rat leg ischemia model,
kisspeptin improved blood flow, induced capillary growth,
and suppressed cell growth in vivo and in vitro detected
with laser doppler. [19]. Several kisspeptin isoforms
including kisspeptin-10, -13, and -54 were detected in
the human coronary artery and umbilical vein [20]. All
cleavage products of kisspeptin activate Kiss1R signalling,
but kisspeptin-10 (Kisspeptin) has been shown to be the
most physiologically active peptide [21,22].
It is known that the striatum is more vulnerable than
the cortex in ischemia [23,24], and kisspeptin may exert a
protective effect on the striatum during ischemia by acting
on catecholamines. Therefore, in this study, the effects of
kisspeptin on levels of dopaminergic and noradrenergic
neurotransmitters before, during, and after transient
cerebral ischemia were determined by brain microdialysis.
In addition, oxidative stress markers and histological
alterations were investigated.

2. Materials and methods
2.1. Animals and experimental setup
Experiments were performed in accordance with National
Health Institute of Health Guidelines for the Care and
Use of Laboratory Animals and ARRIVE guidelines with
local government approval. Ethical approval was obtained
from Local Ethics Committee on Experimental Animal
Research (Approval number: 700). Forty young adult
male C57/BL6 mice weighing 20–25 g were used in this
study. As the menstrual cycle of the female animals and
hormonal changes may have significant impact on the
brain chemistry, male animals were used in the study.
Animals were housed under controlled temperatures (21
± 1°C) and controlled lighting conditions (12-h light/dark
cycle). Standard mouse chow and tap water were provided
ad libitum.
The mice were anaesthetized with isoflurane
(Piramal, USA) and placed on the stereotaxic frame,
the microdialysis probe was placed in the right striatum
according to the coordinates determined by the Mouse
Brain in Stereotaxic Coordinates (antero-posterior = 0.02
mm, medial-lateral = 2 mm, dorsal-ventral = 3 mm) by
Paxinos and Franklin. (Figure 1) [25]. Experimental
groups were as follows: Sham (n = 10), Kisspeptin (n =
10), I/R (n = 10), I/R + Kisspeptin (n = 10). I/R groups
(I/R and I/R + Kisspeptin groups) received either 200
uL physiological saline (Sal) or 20 nmol kisspeptin
intraperitoneally [26] (M2816 Metastin 45-54 amide,

Figure 1. Experimental design. The mice were placed on the stereotaxic frame under anaesthesia, the
microdialysis probe was placed in the right striatum according the coordinates determined by the Mouse
Brain in Stereotaxic Coordinates by Paxinos and Franklin [25] (AP: 0.02 mm, ML: 2 mm, DV: 3 mm).
Artificial cerebrospinal fluid was circulated through the micropump during the experimental period. The
flow rate of artificial cerebrospinal fluid was set at 1.5 uL. Three microlitres of HCl was added to the tubes that
were claimed at the beginning of the microdialysis procedure for degradation of monoamines by monoamine
oxidase inhibition. Microdialysis fluids were collected twice at 20-min intervals as indicated by blue circles.
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human, SIGMA, France) and the artificial cerebrospinal
fluid (aCSF) was prepared as indicated previously [27] and
passed through the micropump (CMA, Sweden) during
the experimental period. The flow rate of aCSF was set at
1.5 µL. Three microlitres of HCl was added to the tubes
at the beginning of the microdialysis procedure to avoid
the degradation of monoamines by monoamine oxidase
inhibition. Microdialysis fluids were collected twice at 20min intervals. At the end of this period, an aneurysm clip
was used to squeeze both of carotid arteries for 15 min
(Figure 1) and one microdialysis fluid was obtained and
then 2 h of reperfusion was performed [28, 29], during
which six microdialysis fluid samples were collected. In
total, 6 µL of sample is collected in the tubes. A total of
nine samples were obtained from each mouse (two samples
before ischemia, one sample during ischemia, and six
samples after reperfusion). In the other two groups (Sham
and Kisspeptin), the same operations were performed
except for the I/R procedure. Study was completed within
6 months (31.09.2018–31.03.2019).
After collecting microdialysis fluid samples at nine time
points, the samples were stored at –80 °C for dopamine
(DA), noradrenaline (NA) and 3,4-dihydroxyphenylglycol
(DHPG) analyses. After decapitation, the striatum was
dissected from the brain tissue. Reduced glutathione
(GSH), glutathione S-transferase (GST), malondialdehyde
(MDA), and superoxide dismutase (SOD) levels were
measured to determine oxidative stress in the striatum. In
addition, the brain tissues of the other five animals were
used for the determination of histological alteration in the
striatum by cresyl violet staining.
2.2. Histological study
At the end of the experimental period, the mice were
decapitated and the brain tissues were frozen on dry ice.
Tissues were sectioned coronally at 20 µm thickness using
a Leica CM1850 UV Cryostat and immersed in different
alcohol concentrations (100%, 95%, and 70%, respectively)
for 5 min. Samples were stained with cresyl violet (0.5 g/mL,
Sigma, France) for 5 min. After the staining, the slides were
treated with different concentrations of alcohol (70%, 95%,
and 100%, respectively) for 5 min and xylene for 20 min.
Afterwards, sections were observed under a microscope with
a fixed digital camera (Zeiss, Germany) at 40× magnifications.
The total number of cells was counted in different groups at
150× magnifications. Images of sections were examined, and
cell counting was performed by Fiji ImageJ software 1.5.2i
(USA). Large cells with pale nuclear staining are marked as
neurons and smaller round or oval nuclei without stained
cytoplasm are considered glia. Small, elongated nuclei are
considered epithelial cells and not included in our counts
[30]. Glial fibrillary acidic protein (GFAP) staining was not
performed since all glial cells would be evaluated rather than
just the distribution of astrocytes [31].
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2.3. Catecholamine analyses
Analytical high pressure liquid chromatography column
(HPLC, Agilent 1260 USA) with an electrochemical
detector (Waters 2465, USA) system was used for
catecholamine analysis. The temperature of the column
furnace was fixed at 40 °C. Flow rate at the HPLC was
set at 1 mL/min during analyses. Injections of 20 µL were
performed. The modified catecholamine mobile phase
solution with 32 mM citric acid (Sigma-Aldrich, USA), 16
mM sodium citrate (Sigma-Aldrich, USA), 0.9 mM sodium
1-heptanesulfonic acid (Sigma-Aldrich, USA), 0.16 mM
EDTA (Sigma-Aldrich, USA), 36 mM tetrahydrofuran
(VNR), 0.02 mM glacial acetic acid (Merc, Germany), and
0.616 mM Methanol (Sigma-Aldrich, USA) at pH 4.9 [32]
were continuously ran into the system.
2.4. Biochemical analyses
GSH, GST, MDA, and SOD measurements were made
spectrophotometrically. Changes in the levels of MDA in the
striatum were analysed as reported by Placer et al. [33]. The
GSH and GST determinations were conducted as reported
by Elman et al. [34] and Habig et al. [35], respectively. SOD
determinations were conducted according to the method
by Sun et al. [36]. Protein concentrations were determined
using the Lowry method [37].
2.5. Statistical analyses
The data were expressed as mean ± standard deviation
(SD). Statistical analyses were conducted by using
GraphPad® Prism statistical analysis software (GraphPad
Software, Inc., USA, ver. 7.0). Number of glia and neuronal
cells were analysed by using one-way analysis of variance
(ANOVA) followed by Tukey’s multiple comparison
test. Catecholamine levels were analysed by using twoway ANOVA followed by Tukey’s multiple comparison
test. GSH, GST, MDA, and SOD levels were analysed
by using one-way ANOVA followed by Tukey’s multiple
comparison test. A p-value lower than 0.05 was accepted
as statistically different.
3. Results
3.1. Histological Assessment of the effect of Kisspeptin
on I/R injury in striatum by cresyl violet staining
Histological assessments of the ischemic injury in the
corpus striatum revealed that I/R increased gliosis, while
small amount of pyknosis was also observed in the Sham
group (Figures 2A and 2C). Microglial and endothelial
cells were observed in Kisspeptin group (Figure 2B). On
the other hand, reduced amounts of pyknotic cells were
observed in the I/R + Kisspeptin group, as well as reduced
ischemic damage (Figure 2D). The cell counting results
revealed that the number of the neurons did not change
significantly in any of the group at the end of experimental
period (Figure 3A; p > 0.05). A small but significant
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increase in the glial cells was observed in Kisspeptin and
I/R + Kisspeptin groups (Figure 3B; p < 0.01 and p < 0.05,
respectively). The total cell numbers were also found to be
increased in both Kisspeptin and I/R + Kisspeptin groups
(Figure 3C; p < 0.05).
3.2. Effect of transient cerebral ischemia and Kisspeptin
administration on catecholamine levels
During the preischemic period, significantly high DA
levels were found in the I/R group compared to the
Sham group (*p(t = -20) < 0.05) likely due to the individual
differences in the animals in both groups (Figure 4A).
No significant differences were observed from the
other groups during the preischemia period (Figure
4A). During the reperfusion period, DA levels were
significantly higher in the I/R group than the other groups
(#p(t = 55 and 135) < 0.0001). DA levels were found similar in
kisspeptin administered I/R animals (I/R + Kisspeptin)
with the DA levels in the Sham and Kisspeptin groups
(Figure 4A).
With regards to NA levels, there were no significant
differences between the groups during the preischemia
period (Figure 4B). The Kisspeptin group exhibited
significantly lower NA levels during the reperfusion

period (at t = 35 min and t = 115 min) compared to the
I/R + Kisspeptin group (*p < 0.05) and the Sham group
(#p(t=115) < 0.05; Figure 4B).
During the preischemic period at t = –20, the Ischemia
group exhibited significantly higher DHPG levels than the
Kisspeptin group (p < 0.01) and I/R + Kisspeptin group (p
< 0.001; Figure 4C). DHPG levels of the Sham group were
significantly higher than those of the I/R + Kisspeptin
group at t = 75 min (pp < 0.05; Figure 4C).
3.3. GSH, GST, MDA, and SOD levels
The effects of carotid artery ischemia on the oxidative
stress parameters in the striatum were determined (Table
1). GSH levels were not affected, while nearly significantly
lower GSH levels were determined in the Kisspeptin group
when compared to the Sham group (Table 1; p = 0.055).
The I/R + Kisspeptin group exhibited significantly lower
GST levels compared to the Kisspeptin group (Table 1; p
< 0.05). MDA levels were not significantly altered when
compared to each other (Table 1; p < 0.01). SOD levels
were significantly lower in the I/R + Kisspeptin group than
the Kisspeptin group. No significant differences in the
oxidative stress parameters were observed between the I/R
and I/R + Kisspeptin groups.

Figure 2. Histological assessment of the effect of kisspeptin on the
ischemic injury in striatum by cresyl violet staining. (a) In the Sham group,
neuronal pyknosis were observed as darkly stained (thin arrows). (b) In the
Kisspeptin group, eosinophilic shrunken cells (thin arrows), microglial cells
(arrowheads), and endothelial cells (thick arrows) were observed. (c) In
I/R group, shrunken neuronal cell bodies were observed and they became
eosinophilic. Damaged tissue with minimal microglial cells (thick black
arrows) were detected, as well as marked neuronal loss and gliosis in the
striatum. (d) I/R + Kisspeptin group diffused activation of microglial nodule
(thick arrows) and reduced pyknotic cells were detected (thin arrows). Scale
bars of the images obtained at 40× magnification represent 200 µm in length.
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Figure 3. Assessment of the effect of kisspeptin on the ischemic injury in striatum
on cell number. (a) Neuron number, (b) glia number, and (c) total cell number.
Statistical analyses: One-way ANOVA followed by Tukey’s multiple comparison test
(*p < 0.05 and **p < 0.01).

Figure 4. Effect of kisspeptin administration on catecholamine levels. (a) DA, (b) NA and (c) DHPG levels were measured from
microdialysis samples. Data are mean ± SD (n = 10 in each group). Statistical analyses: Two-way ANOVA followed by Tukey’s multiple
comparison test.
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Table 1. Effect of ischemia and kisspeptin on GSH, GST, MDA, and SOD levels. Data are mean ± SD (n = 10 in each group except
for the Sham group in MDA analysis, n = 9). Statistical analyses: One-way ANOVA followed by Tukey’s multiple comparison test.
Data sharing the same superscript letters are significantly different than each other.

a
b

Sham

Kisspeptin

I/R

I/R + Kisspeptin

GSH (umol/mL)

14.34 ± 5.79

7.86 ± 4.69

11.27 ± 3.44

12.06 ± 7.40

p-value
(ANOVA)
0.083

GST (µmol/min.mg protein)

13.73 ± 5.54

15.67 ± 7.83 a

11.97 ± 4.04

7.74 ± 2.47 a

0.014

MDA (nmol/g)

1.74 ± 0.88

1.83 ± 0.95

1.64 ± 0.83

2.66 ± 1.14

0.085

SOD (U/mg protein)

0.44 ± 0.20

0.61 ± 0.27 b

0.42 ± 0.17

0.26 ± 0.08 b

0.003

p < 0.05; Kisspeptin group vs I/R + kisspeptin group
p < 0.01; Kisspeptin group vs I/R + kisspeptin group

4. Discussion
In this study, we observed that kisspeptin administered
before transient cerebral ischemia increased glia and
total cell number after I/R. Changes in metabolic activity
suggest that kisspeptin may play a role in I/R damage by
regulating neurotransmitter release, metabolism, and
inflammatory activity in the infarct area.
Ischemic damage causes a variety of neuronal cell
death [38,39]. Eosinophilic necrosis of the neuron [40,41],
gliosis, and neuronal death were previously presented
in different ischemia models [42,43]. Additionally,
induced inflammation upon I/R is also observed [44,45].
Previous studies suggested that kisspeptin is a protector
against neuronal damage caused by oxidative stress [26].
Similarly, kisspeptin acts protective against oxidative
stress in spermatogenic cells [46,47] and liver tissue [48].
Although GST and SOD levels were altered in I/R and I/R
+ Kisspeptin group of animals, we did not observe any
significant improvement in antioxidant activity altered by
I/R injury.
Glial cells are the key immune cells of the brain [49]
upon ischemic injury, they become activated and can be
detected in the injury area as early as 2 h [50]. In addition,
microglia are activated and migrate to the damaged
area upon ischemic stroke [49]. At the early stages of
ischemia, microglial cells are in M1 polarization status,
and M1 polarized microglia release proinflammatory
mediators associated with tissue damage, while those
in the M2 polarization status release antiinflammatory
mediators associated with tissue healing [49]. In this
context, kisspeptin may have a role in the polarization
of the microglial cells towards M2 status, leading to
neuroprotection and tissue repair by only slightly altering
the number of glial cells. However, the role of kisspeptin
on the inflammatory processes needs to be elucidated. In
addition, no glial polarization markers were investigated
in our study; therefore, it would be relevant to investigate
the polarization profiles of glial cells by kisspeptin in I/R
injury.

As known, the neuropeptide kisspeptin encoded by Kiss1
regulates reproduction by stimulating GnRH secretion.
Kiss1-expressing neurons are found primarily in the
hypothalamic anteroventral periventricular (AVPV / PeN)
and arcuate nucleus of hypothalamus (ARC) [51]. In mice,
tyrosine hydroxylase (TH), the rate-limiting enzyme in the
catecholamine synthesis, is coexpressed in most of the AVPV/
PeN Kiss1 cells [52]. Although the intense colocalization
of TH and Kiss1 in AVPV/PeN has been illustrated, the
function of DA produced in these cells was not clearly
identified, and it was suggested that it might not be essential
for puberty or reproduction processes [52]. However, a
previous study showed that DA plays an inhibitory role on
the GnRH secretion by suppressing the LH pulses regulated
by kisspeptin neurons in ARC [53]. Administration of
GnRH analogue, alarelin, was shown to reduce the apoptotic
cell death in the CA1 region of the hippocampus [54].
On the other hand, it was reported that peptides such as
arginine vasopressin (AVP) and gonadotropin inhibitory
hormone (GnIH) and neurotransmitters such as glutamate
and γ-aminobutyric acid (GABA) regulate AVPV kisspeptin
neurons, and AVPV kisspeptin neurons express galanin and
dopamine together [55].
Kisspeptin was previously indicated to have beneficial
effects upon I/R in the uterus and ovary [56]. Another
study suggested that there is a correlation between the
decreased cardiac kisspeptin levels and ischemic heart
disease [57]. On the other hand, kisspeptin was suggested
to suppress endothelial cell growth likely via induction of
cellular senescence [19]. As the DA release and reuptake is
impaired in I/R injury [58], kisspeptin may be regulating
the DA reuptake by glial cells [59] as Kiss1r is expressed in
glial cells [60]; however, the knowledge regarding the role
of Kiss1r in glial cells is very limited.
Various psychosocial and physical stresses activate
peripheral sympatho-adrenomedular and central
catecholaminergic systems to increase circulating
epinephrine and norepinephrine secretion. These stress
hormones, known as catecholamines, trigger a series of
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biological reactions such as increased energy metabolism
to prepare the organism to cope with stressful events and
adapt [61]. Changes in metabolic activity represent the
severity and type of the brain ischemia and determine
the amount of neurotransmitter release upon ischemia.
Excessive neurotransmitter release is strongly associated
with the neuronal damage and death upon cerebral
ischemic damage [62,63]. It has been shown that NMDA
receptors are overstimulated due to excessive glutamate
release [64,65], and other monoamine neurotransmitters
such as DA, serotonin (5-HT) [66,67] and NA [68,69] are
released upon cerebral ischemia and play roles in ischemic
damage. A previous study in gerbils showed that the
regional turnover of homovanillic acid (HA)/DA increased
15 min after 1 h of bilateral brain ischemia [70]. In another
study in which middle cerebral artery occlusion was
performed, the protective effect of administration of the
β-adrenoceptor antagonist, esmolol, and landiolol reduced
the infarct area in rats although the glutamate levels were
reduced, increased NA levels remained unchanged [71].
It was indicated that glutamate stimulates the NA release
in different regions of the brain [72,73]. NA depletion
was reported to improve brain recovery from ischemiainduced damage in rats [74,75], and additionally, NA was
found to modulate the Kiss1 transcript, Kiss protein levels,
by acting on α-1 adrenergic receptors [76].
In our study, we observed decreased NA levels in
Kisspeptin group but not in I/R + Kisspeptin group.
Previously, an increase in the metabolism of NA into
DHPG [77, 78] in the neocortex, CA3, and dentate gyrus
were observed in rats 1 h after ischemia [79]. Similarly,
a significant increase in DHPG levels was found in the
forebrain of rats after ischemia, suggesting a higher NA
turnover rate upon ischemia [80]. In addition, upon
myocardial ischemia, an increase in NA then in DHPG
levels during the ischemic period and a decrease in NA
levels during the reperfusion period were observed [81].
Interestingly, in our study, the I/R group had significantly
higher DHPG levels at the 20th min of the preischemic
period (t = –20) than the other groups. No differences
were observed in animals until 1 h after reperfusion.
Additionally, sham animals exhibited significantly higher

DHPG levels at t = 75 compared to the Kisspeptin and
I/R + Kisspeptin groups, while DHPG levels remained
unchanged at the end of the experimental period. While
these results suggest that kisspeptin may regulate both NA
release and metabolism upon ischemia, these mechanisms
need to be clarified with a longer reperfusion period.
As a subgroup of glial cell populations, astrocytes
have important roles in ischemic injury [82] by regulating
homeostatic balance [83], supplying tropic factors
for neuronal protection [84] and alleviating oxidative
stress [85]. Additionally, GnRH activity and secretion
are regulated by glia [86]. Glia-derived factors such as
prostaglandin E2 [87] and transforming growth factor-β
[88] influence the activity of GnRH neurons. On the other
hand, ischemia is known to increase NA levels but NA levels
decrease during reperfusion [89]. Several studies have
shown that glial activation is mediated by NA [90], while
astrocytes uptake NA [91,92]. Additionally, astrocytes and
synaptic structures are located in close distance, leading
to the exposure of astrocyte to neurotransmitters released
from the synaptic terminals [93]. That may be due to the
fact that glial cells uptake the synaptic NA and represents
it to the other glial cells via noradrenaline-specific
receptor. In our study, after ischemia, the reduction in NA
and subsequent increase in glial population levels in the
kisspeptin group could be explained by that kisspeptin
might regulate the NA uptake and NA-specific receptor
signalling, leading to microglial recruitment. On the
other hand, it is required to elucidate which specific glial
populations are affected by kisspeptin after I/R injury.
In conclusion, our results suggest that kisspeptin may
play a role in I/R injury by regulating neurotransmitter
release, metabolism, and inflammatory activity in
the infarct area. However, one should be cautious in
interpretation when describing the beneficial effects of
Kisspeptin on I/R. In addition to mechanical studies,
longer reperfusion times are needed to observe the longterm effects of Kisspeptin on I/R injury.
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